Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
After a period of relative senescence in the field of vascular smooth muscle cell (VSMC) research with particular regards to atherosclerosis, the last few years has witnessed a resurgence, with extensive research re-assessing potential molecular mechanisms and pathways that modulate VSMC behaviour within the atherosclerotic-prone vessel wall and the atherosclerotic plaque itself. Attention has focussed on the pathological contribution of VSMC in plaque calcification; systemic and local mediators such as inflammatory molecules and lipoproteins; autocrine and paracrine regulators which affect cell-cell and cell to matrix contacts alongside cytoskeletal changes. In this brief focused review, recent insights that have been gained into how a myriad of recently identified factors can influence the pathological behaviour of VSMC and their subsequent contribution to atherosclerotic plaque development and progression has been discussed. An overriding theme is the mechanisms involved in the alterations of VSMC function during atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide synthases: regulation and function
Forstermann, U., & Sessa, W. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr304 · Cited by 4,409
Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A., & Schwartz, S. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1262 · Cited by 4,084
Role of Endothelial Dysfunction in Atherosclerosis
Davignon, J., & Ganz, P. (2004) · Circulation · doi:10.1161/01.cir.0000131515.03336.f8 · Cited by 2,513
Update on acute coronary syndromes: the pathologists' view
Falk, E., Nakano, M., Bentzon, J. F., Finn, A. V., & Virmani, R. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs411 · Cited by 1,047
Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice
Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M., Moriwaki, H., & Seishima, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064374.15232.c3 · Cited by 748
Ridker, P. M., Howard, C. P., Walter, V., Everett, B., Libby, P., Hensen, J., & Thuren, T. (2012) · Circulation · doi:10.1161/circulationaha.112.122556 · Cited by 530
Clarke, M. C. H., Littlewood, T. D., Figg, N., Maguire, J. J., Davenport, A. P., Goddard, M., & Bennett, M. R. (2008) · Circulation Research · doi:10.1161/circresaha.108.175976 · Cited by 396 · cited 2×
“earlier, chronic VSMC apoptosis promotes atherosclerotic plaque calcification and progression.(65) Supportingly, insulin-like growth factor-1 (IGF1) enhances VSMC survival and blocks calcification, in part through moderate calcium induction of osteoprotegerin.”
Clarke, M. C. H., Talib, S., Figg, N. L., & Bennett, M. R. (2010) · Circulation Research · doi:10.1161/circresaha.109.208389 · Cited by 216 · cited 8×
“Collectively, novel approaches to reduce plaque calcification may provide an esoteric approach to stabilize atherosclerotic lesions, particularly mechanisms driven by VSMCs.”
InfluentialNaik, V., Leaf, E. M., Hu, J. H., Yang, H.-Y., Nguyen, N. B., Giachelli, C. M., & Speer, M. Y. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs126 · Cited by 149
Iacobini, C., Menini, S., Ricci, C., Scipioni, A., Sansoni, V., Cordone, S., Taurino, M., Serino, M., Marano, G., Federici, M., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.186791 · Cited by 91
Soluble N-Cadherin Overexpression Reduces Features of Atherosclerotic Plaque Instability
Lyon, C. A., Johnson, J. L., Williams, H., Sala-Newby, G. B., & George, S. J. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.178087 · Cited by 51
Self-citationEwart, M.-A., Kennedy, S., MacMillan, D., Raja, A. L. N., Watt, I. M., & Currie, S. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.02.014 · Cited by 21 · cited 1×
“VSMCs from athero-susceptible mice(52) and also associated with altered SERCA expression and concomitant changes in cell function.(53) Furthermore, alterations in Ca2+ response can regulate the phenotypic switching of in vitro human coronary artery VSMCs.”
Cited by
Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease
Lacolley, P., Regnault, V., Segers, P., & Laurent, S. (2017) · Physiological Reviews · doi:10.1152/physrev.00003.2017 · Cited by 734
Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
Ramji, D. P., & Davies, T. S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.04.003 · Cited by 469
Vascular smooth muscle cell in atherosclerosis
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2015) · Acta Physiologica · doi:10.1111/apha.12466 · Cited by 384
Grootaert, M. O., da Costa Martins, P. A., Bitsch, N., Pintelon, I., De Meyer, G. R., Martinet, W., & Schrijvers, D. M. (2015) · Autophagy · doi:10.1080/15548627.2015.1096485 · Cited by 267
“Although VSMCs are considered beneficial in terms of plaque stability due to the formation of a thick fibrous cap that safeguards plaques from rupturing, VSMCs also play a fundamental role in promoting plaque development.(55) Figure 9.”
BackgroundMatrix ageing and vascular impacts: focus on elastin fragmentation
Duca, L., Blaise, S., Romier, B., Laffargue, M., Gayral, S., El Btaouri, H., Kawecki, C., Guillot, A., Martiny, L., Debelle, L., et al. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw061 · Cited by 260
Metadata
- Authors
- Johnson, J. L.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-07-22
- Volume
- 103
- Issue
- 4
- Pages
- 452-460
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2155737281
- Cited by
- 138
- References
- 12
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.